genprowebdirectory
GEN Edge
News
Insights
Trends for 2021
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Drug Discovery
Delivering on a Promise: The Present and Future of Targeted Protein…
Gene Therapy
OXGENE Eyes Further Growth in Cell and Gene Therapy Services after…
Coronavirus
Breathe In: Theravance Reports Positive Phase II Data for JAK Inhibitor
Cancer
The Life Oncolytic, with Stephen Russell
Synthetic Biology
Flush with Cash, Foresite Aims to Live Up to Its Name
News
Antibodies
Amgen to Acquire Five Prime for $1.9B, Adding Phase III Gastric…
Neuroscience
Ion Channel in Brain May Serve as Novel Target for Treating…
Alzheimers
Dietary Supplement Reverses Effects of Alzheimer’s Disease APOE4 Risk Gene on…
Cancer
Regenerative Collagen Scaffold Offers Better Options for Reconstruction of Soft Tissue…
Cancer
Researchers Reveal Culprit behind Rare Childhood Tumor
Insights
All
Trends for 2021
Trends for 2020
Infectious Diseases
SARS-CoV-2 Under Surveillance
Cancer
Immune Cell Profiles Reveal Cancer’s Leading Indicators
Translational Medicine
Animal Models Offer Improved Translatability
OMICs
Genomic Medicine Stands on the Shoulders of Giants
A-Lists
A-Lists
Top 7 Best Selling COVID-19 Vaccines and Drugs of 2020
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Antibodies
Amgen to Acquire Five Prime for $1.9B, Adding Phase III Gastric…
Drug Discovery
Delivering on a Promise: The Present and Future of Targeted Protein…
Alzheimers
Dietary Supplement Reverses Effects of Alzheimer’s Disease APOE4 Risk Gene on…
Cancer
Regenerative Collagen Scaffold Offers Better Options for Reconstruction of Soft Tissue…
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Magazine
November 1 2006 Vol. 26 No. 19
November 1 2006 Vol. 26 No. 19
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
November 1 2006 Vol. 26 No. 19
Third Quarter Life Science Sector Review
November 1 2006 Vol. 26 No. 19
GenoLogics Automates Omics for Labs
November 1 2006 Vol. 26 No. 19
Biotech Production Is Blooming in the Tropics
November 1 2006 Vol. 26 No. 19
Maximizing the Value of Biotech Patents
November 1 2006 Vol. 26 No. 19
Multiparametric Assays on Individual Cells
November 1 2006 Vol. 26 No. 19
RNAi Libraries for Functional Genomics
November 1 2006 Vol. 26 No. 19
Navigating the Postpreservation Viability Fog
November 1 2006 Vol. 26 No. 19
BioMarket Trends
November 1 2006 Vol. 26 No. 19
Can Pharma & Biotech Foil Counterfeiting?
November 1 2006 Vol. 26 No. 19
Outsourcing Can Add Capacity & Expertise
November 1 2006 Vol. 26 No. 19
Multidisciplinary Approach to RNAi
November 1 2006 Vol. 26 No. 19
Antibody Engineering Methods Advance
November 1 2006 Vol. 26 No. 19
Novel Vaccines Expand Potential Markets
November 1 2006 Vol. 26 No. 19
Small Molecule Drugs
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Blocking PHGDH in tumors that overexpress it halts cell proliferation and cancer growth in vitro and in vivo. [© Arto - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/July14_2011_17369713_BreastCancerPinkRibbon_BreastCancerBresearchEnzyme1951905819-218x150.jpg "Regenerative Collagen Scaffold Offers Better Options for Reconstruction of Soft Tissue in Surgery")
